Implication des calcium/calmoduline-dépendente kinase kinases et du facteur neurotrophique BDNF dans le mécanisme d'action des antidépresseurs

by Vinet, Jonathan

Abstract (Summary)
Major depression is a mood disorder that affect 15% of the population and that can be caused by various factors, including stress. Hypothalamo-pituiary-adrenal axis hyperactivity is present in a majority of depressive patients. Antidepressant drugs are the best therapy that exists to treat depression. They exert their therapeutic action by activating the AMPc signaling pathway and the transcription factor CREB, which leads to an increase in the transcription of genes implicated in cell protection and surviving, like BDNF. CREB can also be activated by the calcium-signaling pathway. This thesis reports the possible implication of the CaMKK? and CaMKK? in the mechanism of action of antidepressants. We first cloned the mRNA of the mouse CaMKK? and described the distribution of both CaMKKs in the mouse central nervous system. They were strongly expressed in brain regions that are implicated in major depression. Next, we used in situ hybridization to study the effect of chronic antidepressant treatment on the gene expression of the CaMKKs. Moreover, we used a transgenic mouse characterized by a dysfunction of the glucocorticoid receptors (GR) as a neuroendocrine model of depression. The analysis of the different levels of expression of the CaMKKs and BDNF shows that different brain areas react to antidepressants or to GR dysfunction. For instance, prefrontal cortex and hippocampus are of particular importance due to their implication in depression. Our results suggest that the calcium siganling pathway might be a target of antidepressant drugs.
This document abstract is also available in French.
Bibliographical Information:

Advisor:Barden, Nicholas

School:Université Laval

School Location:Canada - Quebec / Québec

Source Type:Master's Thesis



Date of Publication:02/01/2005

© 2009 All Rights Reserved.